214 related articles for article (PubMed ID: 7388982)
1. [Hemoperfusion across charcoal in acute hepatic failure in the dog].
Horák J; Horký J; Rábl M
Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982
[No Abstract] [Full Text] [Related]
2. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs.
Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H
Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475
[No Abstract] [Full Text] [Related]
3. Basic study of polyetherurethane coated bead-type activated charcoal for direct hemoperfusion.
Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
Hiroshima J Med Sci; 1983 Mar; 32(1):9-14. PubMed ID: 6863016
[No Abstract] [Full Text] [Related]
4. Haemoperfusion through activated carbon adsorbents in liver failure and hepatic coma.
Bartels O
Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):324-9. PubMed ID: 696211
[No Abstract] [Full Text] [Related]
5. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
[No Abstract] [Full Text] [Related]
6. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
Hew JT; Hart FE; Willson RA
Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
[TBL] [Abstract][Full Text] [Related]
7. [Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases].
Dmitriev AA
Ter Arkh; 1983; 55(6):140-8. PubMed ID: 6351328
[No Abstract] [Full Text] [Related]
8. [Use of a hepatocyte suspension in a hemosorption system in acute hepatic failure (experimental study)].
Margulis MS; Erukhimov EA; Andreĭman LA; Kuznetsov KA; Sorokin IuA
Khirurgiia (Mosk); 1985 Feb; (2):121-4. PubMed ID: 3981921
[No Abstract] [Full Text] [Related]
9. [Clinical results of charcoal hemoperfusion: studies of 55 cases extending over 250 incidents].
Agishi T; Yamashita N; Ota K
Nihon Rinsho; 1980 Dec; 38(12):4697-702. PubMed ID: 7253246
[No Abstract] [Full Text] [Related]
10. Clinical experience with charcoal and resin hemoperfusion.
Hughes R; Williams R
Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
[No Abstract] [Full Text] [Related]
11. Influence of hemoperfusion using polyetherurethane sheet embedded with powdered charcoal (UPC) on middle molecules of hepatic failure dogs.
Kawanishi H; Nishiki M; Kanao M; Nakagawa K; Sugiyama M; Tsuchiya T; Ezaki H
Hiroshima J Med Sci; 1984 Dec; 33(4):633-8. PubMed ID: 6534919
[No Abstract] [Full Text] [Related]
12. [Experience in using hemosorption in treating liver failure].
Skiba VV; Voĭtenko GH; Kolesnikov EB; Zubkov VI; Bondarevskaia TM
Klin Med (Mosk); 1980 Apr; 58(4):87-90. PubMed ID: 7382374
[No Abstract] [Full Text] [Related]
13. Acute liver failure.
Silk DB; Williams R
Br J Hosp Med; 1979 Nov; 22(5):437, 440-1, 445-6. PubMed ID: 540198
[No Abstract] [Full Text] [Related]
14. The development of a new hemoperfusion column: the filmadsorber.
van Berlo A; Verkooyen A; Tangerman A
Int J Artif Organs; 1982 May; 5(3):181-4. PubMed ID: 7107054
[TBL] [Abstract][Full Text] [Related]
15. Direct hemoperfusion with noncoated charcoal of high adsorption capacity derived from thermosetting resin.
Otsubo O; Horiuchi T; Uchima T; Takai N; Tsunetsugu T; Inou T
Trans Am Soc Artif Intern Organs; 1980; 26():124-8. PubMed ID: 7245468
[No Abstract] [Full Text] [Related]
16. Charcoal hemoperfusion for liver failure.
Weston MJ
Lancet; 1982 Oct; 2(8305):983. PubMed ID: 6127478
[No Abstract] [Full Text] [Related]
17. Hemoperfusion: state of the art and future requirements.
Sideman S; Chang TM
Artif Organs; 1980 Feb; 4(1):70-5. PubMed ID: 7369897
[No Abstract] [Full Text] [Related]
18. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
19. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
Omori Y
Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990
[TBL] [Abstract][Full Text] [Related]
20. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.
Silk DB; Williams R
Int J Artif Organs; 1978 Jan; 1(1):29-33. PubMed ID: 669832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
